المؤلفون: Lincoff, A.M., Roe, M., Aylward, P., Galla, J., Rynkiewicz, A., Guetta, V., Zelizko, M., Kleiman, N., White, H., McErlean, E., Erlinge, D., Laine, M., Ferreira, J.M. Dos Santos, Goodman, S., Mehta, S., Atar, D., Suryapranata, H., Jensen, S.E., Forster, T., Fernandez-Ortiz, A., Schoors, D., Radke, P., Belli, G., Brennan, D., Bell, G., Krucoff, M.

المصدر: European Heart Journal, 35, 2516-23
Lincoff, A M, Roe, M, Aylward, P, Galla, J, Rynkiewicz, A, Guetta, V, Zelizko, M, Kleiman, N, White, H, McErlean, E, Erlinge, D, Laine, M, Dos Santos Ferreira, J M, Goodman, S, Mehta, S, Atar, D, Suryapranata, H, Jensen, S E, Forster, T, Fernandez-Ortiz, A, Schoors, D, Radke, P, Belli, G, Brennan, D, Bell, G, Krucoff, M & PROTECTION AMI Investigators 2014, ' Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction : results of the PROTECTION AMI Randomized Controlled Trial ', European Heart Journal, vol. 35, no. 37, pp. 2516-2523 . https://doi.org/10.1093/eurheartj/ehu177Test
European Heart Journal, 35, 37, pp. 2516-23

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, Vascular damage Radboud Institute for Health Sciences [Radboudumc 16], Population, Myocardial Infarction, Infarction, Pilot Projects, Drug Administration Schedule, Percutaneous Coronary Intervention, Reperfusion therapy, Double-Blind Method, Internal medicine, medicine, Creatine Kinase, MB Form, Humans, ST segment, cardiovascular diseases, Myocardial infarction, Infusions, Intravenous, education, Protein Kinase Inhibitors, Aged, education.field_of_study, Ejection fraction, business.industry, Troponin I, Percutaneous coronary intervention, Middle Aged, medicine.disease, Treatment Outcome, Chemotherapy, Adjuvant, Area Under Curve, Conventional PCI, Cardiology, Female, Peptides, Cardiology and Cardiovascular Medicine, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b488880ac21774290f5d0ceccbcd8622Test
https://doi.org/10.1093/eurheartj/ehu177Test

المؤلفون: Whellan, D. J., Green, C. L., Piccini, J. P., Krucoff, M. W.

المصدر: Clinical Pharmacology & Therapeutics; Jul2009, Vol. 86 Issue 1, p101-104, 4p, 1 Diagram, 2 Charts

مصطلحات موضوعية: BIOMARKERS, ELECTROCARDIOGRAPHY, DRUG development, ANTINEOPLASTIC agents, PHARMACOLOGY